Download
s13073-021-00975-y.pdf 2,84MB
WeightNameValue
1000 Titel
  • Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine
1000 Autor/in
  1. Röcken, Christoph |
  2. Amallraja, Anu |
  3. Halske, Christine |
  4. Opasic, Luka |
  5. Traulsen, Arne |
  6. Behrens, Hans-Michael |
  7. Krüger, Sandra |
  8. Liu, Anne |
  9. Haag, Jochen |
  10. Egberts, Jan-Hendrik |
  11. Rosenstiel, Philip |
  12. Meißner, Tobias |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-11-08
1000 Erschienen in
1000 Quellenangabe
  • 13(1):177
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13073-021-00975-y |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576943/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Cancer is a somatic evolutionary disease and adenocarcinomas of the stomach and gastroesophageal junction (GC) may serve as a two-dimensional model of cancer expansion, in which tumor subclones are not evenly mixed during tumor progression but rather spatially separated and diversified. We hypothesize that precision medicine efforts are compromised when clinical decisions are based on a single-sample analysis, which ignores the mechanisms of cancer evolution and resulting intratumoral heterogeneity. Using multiregional whole-exome sequencing, we investigated the effect of somatic evolution on intratumoral heterogeneity aiming to shed light on the evolutionary biology of GC.!##!Methods!#!The study comprised a prospective discovery cohort of 9 and a validation cohort of 463 GCs. Multiregional whole-exome sequencing was performed using samples form 45 primary tumors and 3 lymph node metastases (range 3-10 tumor samples/patient) of the discovery cohort.!##!Results!#!In total, the discovery cohort harbored 16,537 non-synonymous mutations. Intratumoral heterogeneity of somatic mutations and copy number variants were present in all tumors of the discovery cohort. Of the non-synonymous mutations, 53-91% were not present in each patient's sample; 399 genes harbored 2-4 different non-synonymous mutations in the same patient; 175 genes showed copy number variations, the majority being heterogeneous, including CD274 (PD-L1). Multi-sample tree-based analyses provided evidence for branched evolution being most complex in a microsatellite instable GC. The analysis of the mode of evolution showed a high degree of heterogeneity in deviation from neutrality within each tumor. We found evidence of parallel evolution and evolutionary trajectories: different mutations of SMAD4 aligned with different subclones and were found only in TP53 mutant GCs.!##!Conclusions!#!Neutral and non-neutral somatic evolution shape the mutational landscape in GC along its lateral expansions. It leads to complex spatial intratumoral heterogeneity, where lymph node metastases may stem from different areas of the primary tumor, synchronously. Our findings may have profound effects on future patient management. They illustrate the risk of mis-interpreting tumor genetics based on single-sample analysis and open new avenues for an evolutionary classification of GC, i.e., the discovery of distinct evolutionary trajectories which can be utilized for precision medicine.
1000 Sacherschließung
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal B7-H1 Antigen [MeSH]
lokal Evolution, Molecular [MeSH]
lokal Intratumoral heterogeneity
lokal TP53
lokal Cohort Studies [MeSH]
lokal Lymphatic Metastasis [MeSH]
lokal SMAD4
lokal Exome [MeSH]
lokal Sequence Analysis, DNA [MeSH]
lokal Gastric cancer
lokal Stomach Neoplasms/genetics [MeSH]
lokal Clonal Evolution [MeSH]
lokal Mutation [MeSH]
lokal Humans [MeSH]
lokal Genetic Heterogeneity [MeSH]
lokal Precision Medicine/methods [MeSH]
lokal Whole Exome Sequencing [MeSH]
lokal Middle Aged [MeSH]
lokal Smad4 Protein/genetics [MeSH]
lokal Phylogeny [MeSH]
lokal Tumor Suppressor Protein p53/genetics [MeSH]
lokal DNA Copy Number Variations [MeSH]
lokal Targeting cancer evolution in the clinic
lokal Research
lokal Adenocarcinoma/genetics [MeSH]
lokal Evolution
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-6989-8002|https://frl.publisso.de/adhoc/uri/QW1hbGxyYWphLCBBbnU=|https://frl.publisso.de/adhoc/uri/SGFsc2tlLCBDaHJpc3RpbmU=|https://frl.publisso.de/adhoc/uri/T3Bhc2ljLCBMdWth|https://frl.publisso.de/adhoc/uri/VHJhdWxzZW4sIEFybmU=|https://frl.publisso.de/adhoc/uri/QmVocmVucywgSGFucy1NaWNoYWVs|https://frl.publisso.de/adhoc/uri/S3LDvGdlciwgU2FuZHJh|https://frl.publisso.de/adhoc/uri/TGl1LCBBbm5l|https://frl.publisso.de/adhoc/uri/SGFhZywgSm9jaGVu|https://frl.publisso.de/adhoc/uri/RWdiZXJ0cywgSmFuLUhlbmRyaWs=|https://frl.publisso.de/adhoc/uri/Um9zZW5zdGllbCwgUGhpbGlw|https://frl.publisso.de/adhoc/uri/TWVpw59uZXIsIFRvYmlhcw==
1000 Hinweis
  • DeepGreen-ID: ea4e68e6a56b49dea0b619ee424749ca ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
  1. The evolutionary history of 2,658 cancers
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6465946.rdf
1000 Erstellt am 2023-11-16T17:36:20.841+0100
1000 Erstellt von 322
1000 beschreibt frl:6465946
1000 Zuletzt bearbeitet 2023-12-01T03:24:22.409+0100
1000 Objekt bearb. Fri Dec 01 03:24:22 CET 2023
1000 Vgl. frl:6465946
1000 Oai Id
  1. oai:frl.publisso.de:frl:6465946 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source